---
schema_version: "secwatch.filing_event.v1"
accession: "0001121781-21-000023"
form_type: "8-K"
ticker: "GTHP"
cik: "0000924515"
company_name: "GUIDED THERAPEUTICS INC"
filed_at: "2021-07-27T23:59:59+00:00"
generated_at: "2026-06-30T02:25:53.464924+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Guided Therapeutics shareholders approve reverse split and charter changes at annual meeting

## Summary
- All seven proposals approved at July 22, 2021 annual meeting.
- Reverse split up to 1-for-20 authorized; board may decide by Dec 31, 2021; 15.58M for.
- Authorized common reduced from 3B to 500M shares; 15.69M for.
- Series F preferred authorized increased to 4,000 from 1,500; 15.51M for.
- Advisory compensation vote and one-year frequency approved.

## SEC filing metadata
- accession: 0001121781-21-000023
- form_type: 8-K
- ticker: GTHP
- cik: 0000924515
- company_name: GUIDED THERAPEUTICS INC
- filed_at: 2021-07-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/924515/000112178121000023/0001121781-21-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/924515/000112178121000023/gthp8k72721.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001121781-21-000023
- JSON: https://secwatch.observer/filing/0001121781-21-000023.json
- Plain text: https://secwatch.observer/filing/0001121781-21-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.